Incidence of ERBB gene fusions (EGFR, ERBB2, ERBB4) across tumor types.

Authors

null

Laura Schubert

University of Colorado School of Medicine, Denver, CO

Laura Schubert , Andrew Elliott , Robert Charles Doebele , Emil Lou , Hossein Borghaei , Michael J. Demeure , Razelle Kurzrock , Anh T. Le , Joshua E. Reuss , Sai-Hong Ignatius Ou , David R. Braxton , Christian A. Thomas , Sourat Darabi , Wolfgang Michael Korn , Wafik S. El-Deiry , Stephen V. Liu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Track

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Sub Track

New Targets and New Technologies (non-IO)

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 3091)

DOI

10.1200/JCO.2021.39.15_suppl.3091

Abstract #

3091

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Kanwal Pratap Singh Raghav

First Author: Daniel H. Hovelson

Poster

2016 ASCO Annual Meeting

The genomics of young lung cancer.

The genomics of young lung cancer.

First Author: Barbara J. Gitlitz

Poster

2024 ASCO Annual Meeting

<span fontscheme="2">Comprehensive characterization of </span><em fontscheme="2">ERBB2</em><span fontscheme="2"> genomic alterations in</span><em fontscheme="2"> </em><span fontscheme="2">lung cancer.</span>

Comprehensive characterization of ERBB2 genomic alterations in lung cancer.

First Author: Talal El Zarif